Vivos Therapeuticsinc Stock Price History
VVOS Stock | USD 2.57 0.08 3.02% |
If you're considering investing in Vivos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vivos TherapeuticsInc stands at 2.57, as last reported on the 25th of April, with the highest price reaching 2.72 and the lowest price hitting 2.54 during the day. Vivos TherapeuticsInc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Vivos TherapeuticsInc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vivos TherapeuticsInc's Variance of 50.28, coefficient of variation of (651.14), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide.
At this time, Vivos TherapeuticsInc's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Sale Purchase Of Stock is likely to gain to 0.00 in 2024, whereas Common Stock Total Equity is likely to drop 1,566 in 2024. . At this time, Vivos TherapeuticsInc's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 38.75 in 2024, whereas Price Earnings Ratio is likely to drop (1.17) in 2024. Vivos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Vivos |
Sharpe Ratio = -0.1354
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | VVOS |
Estimated Market Risk
6.94 actual daily | 61 61% of assets are less volatile |
Expected Return
-0.94 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vivos TherapeuticsInc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vivos TherapeuticsInc by adding Vivos TherapeuticsInc to a well-diversified portfolio.
Price Book 18.9385 | Enterprise Value Ebitda (0.49) | Price Sales 0.5705 | Shares Float 1.9 M | Wall Street Target Price 7.22 |
Vivos TherapeuticsInc Stock Price History Chart
There are several ways to analyze Vivos Stock price data. The simplest method is using a basic Vivos candlestick price chart, which shows Vivos TherapeuticsInc price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 30, 2024 | 7.55 |
Lowest Price | April 24, 2024 | 2.57 |
Vivos TherapeuticsInc April 25, 2024 Stock Price Synopsis
Various analyses of Vivos TherapeuticsInc's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vivos Stock. It can be used to describe the percentage change in the price of Vivos TherapeuticsInc from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vivos Stock.Vivos TherapeuticsInc Accumulation Distribution | 4,930 | |
Vivos TherapeuticsInc Price Rate Of Daily Change | 0.97 | |
Vivos TherapeuticsInc Price Daily Balance Of Power | (0.44) | |
Vivos TherapeuticsInc Price Action Indicator | (0.10) |
Vivos TherapeuticsInc April 25, 2024 Stock Price Analysis
Vivos Stock Price History Data
The price series of Vivos TherapeuticsInc for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 4.91 with a coefficient of variation of 26.92. The daily prices for the period are distributed with arithmetic mean of 4.66. The median price for the last 90 days is 4.92. The company experienced 1:25 stock split on 27th of October 2023.Open | High | Low | Close | Volume | ||
04/24/2024 | 2.57 | 2.72 | 2.54 | 2.57 | 74,500 | |
04/23/2024 | 2.63 | 2.70 | 2.61 | 2.65 | 35,128 | |
04/22/2024 | 2.65 | 2.73 | 2.57 | 2.64 | 31,000 | |
04/19/2024 | 2.69 | 2.74 | 2.61 | 2.72 | 34,100 | |
04/18/2024 | 2.79 | 2.79 | 2.62 | 2.66 | 63,122 | |
04/17/2024 | 2.70 | 2.75 | 2.55 | 2.66 | 30,600 | |
04/16/2024 | 2.71 | 2.76 | 2.52 | 2.70 | 74,818 | |
04/15/2024 | 2.58 | 2.90 | 2.45 | 2.77 | 232,254 | |
04/12/2024 | 2.79 | 2.79 | 2.57 | 2.64 | 87,800 | |
04/11/2024 | 2.77 | 2.79 | 2.40 | 2.74 | 155,700 | |
04/10/2024 | 2.65 | 2.80 | 2.60 | 2.68 | 232,731 | |
04/09/2024 | 3.02 | 3.44 | 2.47 | 2.76 | 5,191,400 | |
04/08/2024 | 3.01 | 3.10 | 2.94 | 3.03 | 36,661 | |
04/05/2024 | 2.96 | 3.14 | 2.95 | 3.01 | 91,146 | |
04/04/2024 | 3.12 | 3.75 | 2.96 | 3.14 | 646,598 | |
04/03/2024 | 3.40 | 3.44 | 2.94 | 3.01 | 160,235 | |
04/02/2024 | 3.46 | 3.46 | 3.25 | 3.39 | 70,500 | |
04/01/2024 | 3.75 | 3.99 | 3.33 | 3.37 | 396,036 | |
03/28/2024 | 4.76 | 4.85 | 4.31 | 4.83 | 59,227 | |
03/27/2024 | 4.64 | 4.70 | 4.39 | 4.65 | 45,427 | |
03/26/2024 | 4.61 | 4.74 | 4.11 | 4.47 | 74,434 | |
03/25/2024 | 4.80 | 4.90 | 4.42 | 4.55 | 41,399 | |
03/22/2024 | 4.89 | 5.24 | 4.56 | 4.94 | 80,880 | |
03/21/2024 | 4.64 | 5.14 | 4.64 | 4.91 | 89,420 | |
03/20/2024 | 4.38 | 4.62 | 4.38 | 4.60 | 31,168 | |
03/19/2024 | 4.32 | 4.63 | 4.32 | 4.45 | 61,102 | |
03/18/2024 | 4.62 | 4.77 | 4.46 | 4.47 | 58,983 | |
03/15/2024 | 4.30 | 4.67 | 4.27 | 4.50 | 50,131 | |
03/14/2024 | 4.50 | 4.65 | 4.21 | 4.26 | 76,123 | |
03/13/2024 | 4.55 | 4.72 | 4.45 | 4.51 | 46,220 | |
03/12/2024 | 4.66 | 4.89 | 4.55 | 4.56 | 53,062 | |
03/11/2024 | 4.92 | 4.98 | 4.35 | 4.76 | 50,000 | |
03/08/2024 | 5.01 | 5.21 | 4.78 | 4.83 | 70,300 | |
03/07/2024 | 5.18 | 5.30 | 4.94 | 5.08 | 32,914 | |
03/06/2024 | 5.25 | 5.35 | 4.95 | 5.31 | 69,492 | |
03/05/2024 | 5.42 | 5.50 | 4.87 | 5.04 | 73,566 | |
03/04/2024 | 5.39 | 5.71 | 5.15 | 5.30 | 85,343 | |
03/01/2024 | 5.55 | 5.84 | 5.40 | 5.49 | 71,392 | |
02/29/2024 | 5.16 | 6.23 | 5.02 | 5.81 | 318,637 | |
02/28/2024 | 4.86 | 5.22 | 4.79 | 5.20 | 80,260 | |
02/27/2024 | 4.95 | 5.01 | 4.84 | 4.92 | 69,954 | |
02/26/2024 | 5.18 | 5.20 | 4.87 | 4.91 | 73,270 | |
02/23/2024 | 5.18 | 5.18 | 4.75 | 4.90 | 61,102 | |
02/22/2024 | 5.00 | 5.14 | 4.86 | 4.95 | 29,900 | |
02/21/2024 | 5.00 | 5.15 | 4.77 | 4.93 | 87,840 | |
02/20/2024 | 5.30 | 5.50 | 5.02 | 5.13 | 59,419 | |
02/16/2024 | 5.64 | 5.64 | 5.17 | 5.25 | 54,672 | |
02/15/2024 | 5.01 | 5.51 | 5.01 | 5.36 | 90,754 | |
02/14/2024 | 5.02 | 5.41 | 4.97 | 5.05 | 112,262 | |
02/13/2024 | 5.00 | 5.46 | 4.98 | 5.15 | 121,954 | |
02/12/2024 | 5.30 | 5.68 | 4.97 | 5.14 | 134,280 | |
02/09/2024 | 5.14 | 5.50 | 5.07 | 5.29 | 101,780 | |
02/08/2024 | 5.11 | 5.50 | 4.96 | 5.25 | 115,022 | |
02/07/2024 | 5.51 | 5.52 | 4.90 | 5.03 | 279,675 | |
02/06/2024 | 6.42 | 6.45 | 5.47 | 5.47 | 545,494 | |
02/05/2024 | 5.99 | 6.06 | 5.75 | 5.75 | 51,357 | |
02/02/2024 | 6.30 | 6.47 | 5.90 | 6.13 | 85,461 | |
02/01/2024 | 7.43 | 7.62 | 6.02 | 6.14 | 174,771 | |
01/31/2024 | 7.39 | 7.74 | 7.02 | 7.37 | 143,323 | |
01/30/2024 | 6.48 | 9.14 | 6.16 | 7.55 | 919,411 | |
01/29/2024 | 5.49 | 7.30 | 5.40 | 6.60 | 522,369 |
About Vivos TherapeuticsInc Stock history
Vivos TherapeuticsInc investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vivos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vivos TherapeuticsInc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vivos TherapeuticsInc stock prices may prove useful in developing a viable investing in Vivos TherapeuticsInc
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.2 M | 899.6 K | |
Net Loss | -18.3 M | -19.2 M |
Vivos TherapeuticsInc Stock Technical Analysis
Vivos TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Vivos TherapeuticsInc Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vivos TherapeuticsInc's price direction in advance. Along with the technical and fundamental analysis of Vivos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vivos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (1.20) | |||
Total Risk Alpha | (2.07) | |||
Treynor Ratio | (0.91) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
CEOs Directory Screen CEOs from public companies around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.